Adamas Pharmaceuticals Inc - FORM 10-K - EX-21.1 - February 25, 2020

Attached files

file filename
10-K - 10-K - Adamas Pharmaceuticals Incadms-20191231.htm
EX-23.1 - EX-23.1 - Adamas Pharmaceuticals Incadms10k2019ex231.htm
EX-32.1 - EX-32.1 - Adamas Pharmaceuticals Incadms10k2019ex321.htm
EX-4.4 - EX-4.4 - Adamas Pharmaceuticals Incadms10k2019ex44.htm
EX-31.1 - EX-31.1 - Adamas Pharmaceuticals Incadms10k2019ex311.htm
EX-31.2 - EX-31.2 - Adamas Pharmaceuticals Incadms10k2019ex312.htm
EX-10.37 - EX-10.37 - Adamas Pharmaceuticals Incadms10k2019ex1037.htm
EX-10.6 - EX-10.6 - Adamas Pharmaceuticals Incadms10k2019ex106.htm
EX-10.41 - EX-10.41 - Adamas Pharmaceuticals Incadms10k2019ex1041.htm

Exhibit 21.1
 
ADAMAS PHARMACEUTICALS, INC. SUBSIDIARIES
 
NAME OF SUBSIDIARYJURISDICTION OF INCORPORATION
Adamas Pharma, LLCDelaware, USA


Adamas Pharmaceuticals Inc Reports